Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Tue Apr 01 20:31:49 GMT 2025
by
admin
on
Tue Apr 01 20:31:49 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | AUTOLOGOUS HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | blood |
| Fraction Material Type | cell |
| Fraction Name | t-cell |
| Record UNII |
A4O2H9W17Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10522
Created by
admin on Tue Apr 01 20:31:49 GMT 2025 , Edited by admin on Tue Apr 01 20:31:49 GMT 2025
|
PRIMARY | |||
|
C133718
Created by
admin on Tue Apr 01 20:31:49 GMT 2025 , Edited by admin on Tue Apr 01 20:31:49 GMT 2025
|
PRIMARY | |||
|
DE-62
Created by
admin on Tue Apr 01 20:31:49 GMT 2025 , Edited by admin on Tue Apr 01 20:31:49 GMT 2025
|
PRIMARY | |||
|
A4O2H9W17Y
Created by
admin on Tue Apr 01 20:31:49 GMT 2025 , Edited by admin on Tue Apr 01 20:31:49 GMT 2025
|
PRIMARY | |||
|
100000176455
Created by
admin on Tue Apr 01 20:31:49 GMT 2025 , Edited by admin on Tue Apr 01 20:31:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ANTIGEN->IMMUNE RESPONSIVE CELLS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| TRANSDUCTION | ANTIGEN EXPRESSION | TRANSDUCING VECTOR |
|
UNSPECIFIED SUBSTANCE | 273473d9 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | UNSPECIFIED SUBSTANCE |
0c163cce
(not in database)
|